疑似肺栓塞患者结局的系统综述与荟萃分析
该系统综述与荟萃分析纳入22项研究共15 865例疑似肺栓塞患者,评估了死亡率、复发静脉血栓栓塞、大出血等结局。确诊并抗凝出院的患者3个月全因死亡率5.69%,肺栓塞死亡率1.19%,复发VTE 1.38%,大出血0.90%。低或中度验前概率且D-二聚体阴性者3个月肺栓塞死亡率为0%,VTE发生率分别为0.37%和0.46%。
要点
- 确诊肺栓塞并抗凝出院患者3个月全因死亡率为5.69%,肺栓塞死亡率为1.19%。
- 低或中度验前概率且D-二聚体阴性者3个月肺栓塞死亡率为0%。
- 高验前概率且CT阴性者3个月肺栓塞死亡率为0%,VTE发生率为0.84%。
核心结论
- 疑似肺栓塞患者经诊断路径评估后,不同验前概率和诊断检查结果组的3个月肺栓塞死亡率和VTE发生率均较低。
研究设计与样本
- 系统综述与荟萃分析,检索Cochrane Central、MEDLINE和Embase等数据库,纳入22项研究共15 865例疑似肺栓塞患者。
主要发现
- 确诊肺栓塞并抗凝出院患者3个月全因死亡率为5.69%(91/1599;95%CI 4.56-6.83)。
- 确诊肺栓塞并抗凝出院患者3个月肺栓塞死亡率为1.19%(19/1597;95%CI 0.66-1.72)。
- 确诊肺栓塞并抗凝出院患者3个月复发VTE发生率为1.38%(22/1597;95%CI 0.81-1.95)。
- 确诊肺栓塞并抗凝出院患者3个月大出血发生率为0.90%(2/221;95%CI 0-2.15)。
- 低验前概率且D-二聚体阴性者3个月肺栓塞死亡率为0%(0/808),VTE发生率为0.37%(4/1094;95%CI 0.007-0.72)。
关键数值与推荐
- 低验前概率且D-二聚体阴性者3个月肺栓塞死亡率0%(0/808),VTE发生率0.37%(4/1094;95%CI 0.007-0.72)。
- 中度验前概率且D-二聚体阴性者3个月肺栓塞死亡率0%(0/2747),VTE发生率0.46%(14/3015;95%CI 0.22-0.71)。
- 高验前概率且CT阴性者3个月肺栓塞死亡率0%(0/651),VTE发生率0.84%(11/1302;95%CI 0.35-1.34)。
临床怎么用
- 对疑似肺栓塞患者,可依据验前概率联合D-二聚体或CT的诊断路径评估3个月血栓栓塞风险。
- 低或中度验前概率且D-二聚体阴性者3个月肺栓塞死亡率为0%,支持据此排除肺栓塞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prompt evaluation and therapeutic intervention of suspected pulmonary embolism (PE) are of paramount importance for improvement in outcomes. We systematically reviewed outcomes in patients with suspected PE, including mortality, incidence of recurrent PE, major bleeding, intracranial hemorrhage, and postthrombotic sequelae. We searched the Cochrane Central Register of Controlled Trials, MEDLINE, and Embase for eligible studies, reference lists of relevant reviews, registered trials, and relevant conference proceedings. We included 22 studies with 15 865 patients. Among patients who were diagnosed with PE and discharged with anticoagulation, 3-month follow-up revealed that all-cause mortality was 5.69% (91/1599; 95% confidence interval [CI], 4.56-6.83), mortality from PE was 1.19% (19/1597; 95% CI, 0.66-1.72), recurrent venous thromboembolism (VTE) occurred in 1.38% (22/1597; 95% CI: 0.81-1.95), and major bleeding occurred in 0.90% (2/221%; 95% CI, 0-2.15). In patients with a low pretest probability (PTP) and negative D-dimer, 3-month follow-up revealed mortality from PE was 0% (0/808) and incidence of VTE was 0.37% (4/1094; 95% CI: 0.007-0.72). In patients with intermediate PTP and negative D-dimer, 3-month follow-up revealed that mortality from PE was 0% (0/2747) and incidence of VTE was 0.46% (14/3015; 95% CI: 0.22-0.71). In patients with high PTP and negative computed tomography (CT) scan, 3-month follow-up revealed mortality from PE was 0% (0/651) and incidence of VTE was 0.84% (11/1302; 95% CI: 0.35-1.34). We further summarize outcomes evaluated by various diagnostic tests and diagnostic pathways (ie, D-dimer followed by CT scan).
引用
- Patel P, Patel P, Bhatt M, et al. Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism. Blood Adv. 2021. PMID: 33900385. doi:10.1182/bloodadvances.2020002398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。